Find more stories in our archive
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. As of December 31, 2025, we cared for more than 292,000 patients in our global network of roughly 3,600 dialysis centers worldwide. At the same time, we operated around 35 production sites on all continents, to provide dialysis products such as dialysis machines, dialysers and related disposables.
Fresenius Medical Care aims to further consolidate its expertise and to use this competence as a basis for sustainable, profitable growth. We aim to continuously improve our patients’ quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.
Fresenius Medical Care’s corporate headquarters is in Bad Homburg v. d. Höhe, Germany. The headquarters in North America is in Waltham, Massachusetts, the headquarters of Asia-Pacific is located in Hongkong and the headquarters of Latin America is in Rio de Janeiro.
Further information about our corporate culture and strategy can be found on our global website.
Foundation of the Hirsch Pharmacy in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.
Else Fernau, later Else Kröner, takes over responsibility for the pharmacy and the company after obtaining her pharmacy degree.
Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.
Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year the company sets a new record.
Fresenius Medical Care continues its success as the leading manufacturer of dialyzers, producing its 500,000,000th dialyzer.
Fresenius Medical Care produces the 1,000,000,000th dialyzer.
A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy.
Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.
Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets.
By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility.
Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years.
Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.
Healthcare Professionals (HCPs)
Legal and regulatory
UK-GENINFO-000007 Date Of Preparation: March 2025 © Fresenius Medical Care UK Ltd 2026